Chicago, November 30^th, 2025:  Krsnaa Diagnostics Ltd. (BSE: 543328 | NSE: KRSNAA), one of India’s fastest-growing and largest diagnostic service providers, today announced a strategic and first-of-its-kind collaboration with Arcmedix, a leading global healthcare-technology company specializing in medical asset lifecycle management. The agreement was formalized at the Radiological Society of North America (RSNA) 2025 conference in Chicago, marking Krsnaa Diagnostics’ debut appearance at one of the world’s most influential radiology gatherings.

This partnership represents a powerful step forward in Krsnaa Diagnostics’ long-term strategy to build India’s most reliable, efficient, and technology-driven diagnostic ecosystem. By integrating Arcmedix’s secure and unified asset lifecycle platform, Krsnaa Diagnostics will significantly enhance uptime of critical radiology and pathology equipment, elevate preventive maintenance capabilities, and unlock substantial operational efficiencies across its nationwide network.

With a presence across 3,600+ diagnostic centers in 18 States and Union Territories, including 185+ advanced CT/MRI centers and 1,500+ radiology and tele-reporting facilities, Krsnaa Diagnostics operates one of India’s most comprehensive diagnostic infrastructures. Having served over 75 million patients, the company continues to lead the country in accessible, affordable, and high-quality diagnostic care.

The collaboration will enable Krsnaa Diagnostics to digitalize and standardize the entire lifecycle of thousands of high-value imaging and laboratory assets including CT, MRI, X-ray, ultrasound, and pathology equipment ushering in a new era of visibility, predictability, and performance optimization.

Through Arcmedix’s unified platform, Krsnaa Diagnostics will:

• Digitize and standardize asset workflows for transparency and real-time decision-making across all locations.
• Enhance preventive maintenance and equipment uptime through IoT-enabled monitoring and predictive analytics.
• Maximize asset utilization and ROI, ensuring consistent performance across the network.
• Strengthen compliance, traceability, and audit readiness across multi-state operations.

This strategic transformation reinforces Krsnaa Diagnostics’ commitment to delivering uninterrupted, best-in-class diagnostic services particularly in underserved regions where equipment uptime and operational reliability directly influence health outcomes.

The collaboration has begun with a pilot deployment across flagship diagnostic hubs and will expand nationwide in a phased rollout. This initiative sets a new industry benchmark and positions Krsnaa Diagnostics at the forefront of digital transformation in healthcare operations.

Commenting on the development, Mr. Yash Mutha, Managing Director, Krsnaa Diagnostics Limited said:

“This partnership marks a pivotal moment in our journey toward building India’s most future-ready diagnostic platform. At Krsnaa Diagnostics, we are deeply committed to operational excellence, and Arcmedix brings world-class technological capabilities that will help us accelerate that vision.

By deploying a fully digital and predictive asset management ecosystem, we will not only strengthen reliability and uptime across our radiology and pathology infrastructure but also unlock significant long-term efficiencies and scalability.

As we continue to expand our footprint across India, this collaboration ensures that every patient regardless of their location receives timely, accurate, and uninterrupted diagnostic services. We believe this is a transformative leap that positions Krsnaa Diagnostics strongly for the next phase of sustainable, technology-led growth.”

Commenting on the development, Jean-Sébastien Blot, Co-founder, Arcmedix said:

“We are honored to partner with Krsnaa Diagnostics, a true pioneer in large-scale diagnostic delivery. Their nationwide presence and impact on millions of patients make this collaboration both meaningful and highly scalable.

With Arcmedix’s platform, we look forward to enabling Krsnaa with complete visibility, optimized workflows, and smarter asset decisions ensuring that mission-critical equipment always performs at its highest level.

Together, we are setting a new benchmark for diagnostic reliability, compliance, and operational excellence not only in India but across global healthcare frameworks.”

About Krsnaa Diagnostics Limited

Krsnaa Diagnostics Ltd. (BSE: 543328 | NSE: KRSNAA), is one of India’s largest and fastest-growing diagnostic service providers, operating over 3,600+ centers across 18 states and union territories. With specialized capabilities in radiology, pathology, and tele-radiology, Krsnaa has served more than 75 million patients nationwide. The company remains committed to expanding access to high-quality, affordable diagnostics through both public-private partnerships and private facilities.

Website: www.krsnaadiagnostics.com